Brown Brothers Harriman & CO Bio Techne Corp Transaction History

Brown Brothers Harriman & CO

$14 Billion
Q3 2024

A detailed history of Brown Brothers Harriman & CO transactions in Bio Techne Corp stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 449 shares of TECH stock, worth $32,790. This represents 0.0% of its overall portfolio holdings.

Number of Shares

449

Previous 409 9.78%

Holding current value

$32,790

Previous $29,000 20.69%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$70.96 - $82.35 $2,838 - $3,294	40 Added 9.78%	449 $35,000
Q2 2024 Aug 09, 2024	BUY	$62.12 - $84.15 $22,922 - $31,051	369 Added 922.5%	409 $29,000
Q4 2023 Feb 12, 2024	SELL	$52.83 - $78.22 $211 - $312	-4 Reduced 9.09%	40 $3,000
Q2 2023 Aug 07, 2023	SELL	$73.76 - $85.98 $2,876 - $3,353	-39 Reduced 46.99%	44 $3,000
Q1 2023 May 11, 2023	SELL	$71.62 - $86.62 $5,514 - $6,669	-77 Reduced 48.13%	83 $6,000
Q4 2022 Feb 09, 2023	BUY	$80.67 - $352.29 $5,808 - $25,364	72 Added 81.82%	160 $13,000
Q3 2022 Nov 10, 2022	BUY	$282.54 - $391.85 $13,561 - $18,808	48 Added 120.0%	88 $25,000
Q2 2022 Aug 11, 2022	SELL	$322.67 - $449.65 $645 - $899	-2 Reduced 4.76%	40 $14,000
Q1 2021 May 13, 2021	BUY	$314.62 - $411.0 $10,067 - $13,152	32 Added 320.0%	42 $16,000
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $2,469 - $3,218	10 New	10 $3,000
Q4 2019 Feb 14, 2020	SELL	$189.68 - $222.09 $4,552 - $5,330	-24 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$188.72 - $215.43 $188 - $215	-1 Reduced 4.0%	24 $5,000
Q3 2018 Nov 14, 2018	BUY	$147.44 - $204.11 $3,686 - $5,102	25 New	25 $5,000
Q1 2018 May 14, 2018	SELL	$131.46 - $151.04 $3,286 - $3,776	-25 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$121.17 - $134.75 $3,029 - $3,368	25	25 $3,000

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.86B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account

Brown Brothers Harriman & CO Bio Techne Corp Transaction History